Distribution of Th17 Cells and Foxp3-expressing T Cells in Tumor-infiltrating Lymphocytes in Patients with Uterine Cervical Cancer
Overview
Affiliations
Background: Recent studies suggest a potential impact of Th17 cells on tumor. In the present study, we investigated the distribution of Th17 cells in relation to Foxp3-expressing T cells in the tumor-infiltrating lymphocytes (TILs) from patients with uterine cervical cancer (UCC), cervical tissues from patients with cervical intraepithelial neoplasia (CIN) and healthy cervical tissues.
Methods: Th17 cells and Foxp3-expressing T cells were evaluated by immunohistochemical staining. IL-6, TGF-β, IL-17 and IL-10 were detected by enzyme-linked immunosorbent assay (ELISA). Immunohistochemical staining for microvessel density (MVD) was performed in order to assess the association of IL-17 expression with angiogenesis.
Results: Compared with controls, patients with UCC or CIN had a higher proportion of Th17 cells and Foxp3-expressing T cells, when the ratio of Th17/Foxp3-expressing T cells in TILs was decreased in individual cases, it was more markedly decreased in TILs than normal cervical tissues. Meanwhile, the cytokine(IL-6, TGF-β and IL-10) concentrations were significantly higher in UCC patients than those in healthy controls. Interestingly, the levels of intratumoral Th17 cells were positively correlated with MVD in tumors.
Conclusions: The imbalance of Th17/Foxp3-expressing T cells may play critical roles in the development and progression of UCC and Th17 cells may promote tumor progression by fostering angiogenesis.
The prognostic value of Th17/Treg cell in cervical cancer: a systematic review and meta-analysis.
Zhang J, Zhan J, Guan Z, Lin X, Li T, Li M Front Oncol. 2024; 14:1442103.
PMID: 39324000 PMC: 11422014. DOI: 10.3389/fonc.2024.1442103.
The immune microenvironment of cancer of the uterine cervix.
Mastrogeorgiou M, Chatzikalil E, Theocharis S, Papoudou-Bai A, Peoch M, Mobarki M Histol Histopathol. 2024; 39(10):1245-1271.
PMID: 38483012 DOI: 10.14670/HH-18-727.
Wang Z, Deng Z, Dai F, Yuan M, Liu S, Li B Exp Ther Med. 2024; 27(4):166.
PMID: 38476909 PMC: 10928974. DOI: 10.3892/etm.2024.12453.
Li Y, Gao X, Huang Y, Zhu X, Chen Y, Xue L Front Oncol. 2023; 13:1114042.
PMID: 37234990 PMC: 10206119. DOI: 10.3389/fonc.2023.1114042.
Pena Avila J, Carvalho B, Coimbra E Cancers (Basel). 2023; 15(4).
PMID: 36831674 PMC: 9954575. DOI: 10.3390/cancers15041333.